
Our sister site, Drug Delivery Business News, reports today that CEO Geoff Martha and Que Dallara, EVP and president of Medtronic Diabetes, spoke at the conference about future plans and next-generation technologies.
Among the topics covered were the company’s refreshed continuous glucose monitor (CGM) portfolio and a potential future insulin patch pump.
“You’ve seen us turn around this business over the last couple of years,” Martha said. “It’s grown above our corporate average for the past six quarters and we don’t see this stopping anytime soon.”
Get the full story at our sister site, Drug Delivery Business News.